Sign In
Buy LH
$258.92
+1.22 (+0.473%)
At Close: Jun 03, 2026
Here's Why Investors Should Hold Labcorp (LH) Stock for Now
09:46am, Monday, 26'th Feb 2024
Targeted development in high-growth areas and strategic partnerships bode well for Labcorp (LH).
Is Labcorp (LH) Stock Undervalued Right Now?
10:46am, Friday, 23'rd Feb 2024
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Labcorp (LH) Moves to Buy: Rationale Behind the Upgrade
01:01pm, Wednesday, 21'st Feb 2024
Labcorp (LH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
LH vs. COO: Which Stock Is the Better Value Option?
12:46pm, Wednesday, 21'st Feb 2024
Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Labcorp (LH) or The Cooper Companies (COO). But which of these two companies is the best option for t
Compared to Estimates, Labcorp (LH) Q4 Earnings: A Look at Key Metrics (Revised)
07:31am, Monday, 19'th Feb 2024
Although the revenue and EPS for Labcorp (LH) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street
Labcorp (LH) Surpasses Q4 Earnings and Revenue Estimates (Revised)
08:16am, Friday, 16'th Feb 2024
Labcorp (LH) came out with quarterly earnings of $3.30 per share, beating the Zacks Consensus Estimate of $3.29 per share. This compares to earnings of $3.05 per share a year ago.
Labcorp (LH) Surpasses Q4 Earnings and Revenue Estimates (Revised)
06:26am, Friday, 16'th Feb 2024
Labcorp (LH) came out with quarterly earnings of $3.30 per share, beating the Zacks Consensus Estimate of $3.29 per share. This compares to earnings of $3.05 per share a year ago.
Labcorp (LH) Q4 Earnings and Revenues Beat, Margins Fall
01:51pm, Thursday, 15'th Feb 2024
Strength in Diagnostics Laboratories and Biopharma Laboratory Services businesses contributes to Labcorp's (LH) Q4 performance.
Laboratory Corporation of America Holdings (LH) Q4 2023 Earnings Conference Call Transcript
01:08pm, Thursday, 15'th Feb 2024
Laboratory Corporation of America Holdings (LH) Q4 2023 Earnings Conference Call Transcript
Compared to Estimates, Labcorp (LH) Q4 Earnings: A Look at Key Metrics
10:31am, Thursday, 15'th Feb 2024
Although the revenue and EPS for Labcorp (LH) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street
Labcorp (LH) Surpasses Q4 Earnings and Revenue Estimates
09:11am, Thursday, 15'th Feb 2024
Labcorp (LH) came out with quarterly earnings of $3.30 per share, beating the Zacks Consensus Estimate of $3.29 per share. This compares to earnings of $4.14 per share a year ago.
Analysts Estimate Labcorp (LH) to Report a Decline in Earnings: What to Look Out for
11:06am, Thursday, 08'th Feb 2024
Labcorp (LH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LabCorp (LH) Unveils Test for Preeclampsia in Pregnant Women
01:30pm, Thursday, 01'st Feb 2024
LabCorp (LH) test System, which is available through clinicians, is the first FDA-cleared biomarker test to aid in the risk assessment of progression to severe preeclampsia.
Oncology Space Gains Momentum: 3 Stocks in Focus
10:50am, Tuesday, 23'rd Jan 2024
Stocks such as EXAS, DGX and LH are likely to potentially continue the momentum in the oncology field.
LabCorp (LH) to Expand Clinical Trails Access With New Pact
12:48pm, Thursday, 11'th Jan 2024
LabCorp (LH) and Hawthorne Effect hope to enhance decentralized clinical trials by merging existing services and developing fresh, unique service offers.
